Objective: Thyroid and glucocorticoid hormones are critical for heart maturation. We hypothesized that their addition to standard protocols would promote T-tubule development and mature excitation-contraction coupling of hiPSC-CM when cultured on extracellular matrix with physiological stiffness (Matrigel mattress). 
H uman-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are increasingly being used in biomedical research for cardiac disease modeling, cardiotoxicity screening, and regeneration of injured myocardium. 1, 2 Although considerable advances have been made in the maturation of hiPSC-CM, 2 the lack of T-tubule formation and respective functional consequences remain a major limitation. [3] [4] [5] [6] T-tubules are organized invaginations in the cardiomyocyte sarcolemma and are critical for the synchronous Ca-induced Ca release (CICR) that underlies efficient excitation-contraction (EC) coupling in human ventricular myocardium. Reduced T-tubule formation contributes to abnormal EC coupling in heart failure and may be responsible for the ventricular arrhythmias observed after cardiac transplantation of hiPSC-CM.
complex techniques, such as nanopatterning or tissue engineering; however, the extent of T-tubule formation and its functional contribution to EC coupling has not been demonstrated. 8, 9 Thyroid and glucocorticoid hormones are critical for cardiac maturation during development. 10, 11 Although standard hiPSC-CM induction media contains both factors, supplementing the culture media with higher concentrations of thyroid or glucocorticoid was found to enhance cardiomyocyte maturation. [11] [12] [13] Independently, we and others have shown improved contractility and electrophysiological maturation when culturing hiPSC-CM on extracellular matrix substrates of physiological stiffness. 8, 14 We hypothesized that a combination of the thyroid hormone T3 (triiodothyronine) and the glucocorticoid Dex (dexamethasone) with the flexible Matrigel substrate method 14 would enhance the structural and functional maturation of hiPSC-CM. As such, at days 16 to 30 of the standard chemical differentiation protocol, the maintenance medium was supplemented with a combination T3 and Dex. Cells were dissociated after day 30 followed by single-cell culture on Matrigel mattress for an additional 5 days before experimental analyses.
Methods
T3+Dex-treated cells were generated as depicted in Figure 1A . In brief, media was supplemented with 100 nmol/L T3 and 1000 nmol/L Dex in 3 mL of media/well during days 16 to 30 of hiPSC-CM maintenance. Detailed materials and methods are included in the Online Data Supplement.
Results

T3+Dex Promotes T-Tubule Formation and Synchronizes Intracellular Ca Release
hiPSC-CMs were stained using a lipophilic membrane dye and imaged using a confocal microscope. Images were deconvolved, and thresholded to the mean fluorescence intensity of the entire cell, and T-tubule density calculated by normalizing the suprathreshold signal within the cell interior to cross-sectional cell area. 15 Consistent with previous reports, vehicle-treated cells essentially lacked T-tubules ( Figure 1B) . Treatment with either T3 or Dex alone did not significantly impact T-tubule density, whereas the combination of T3+Dex promoted T-tubule formation ( Figure 1B and Online Movies I and II). Notably, maturation on Matrigel mattress was required for T-tubule formation because T3+Dex-treated cells plated without Matrigel mattress were not different from control cells ( Figure 1B ). Cellular staining for BIN1 (bridging integrator 1), JP2 (junctophilin-2), and Cav3 (caveolin-3), 3 regulators of T-tubule genesis, 16, 17 demonstrated striking changes in their subcellular localization. Although these T-tubule markers were located mostly perinuclear in vehicletreated cells, after T3+Dex treatment, staining was much more prominent throughout the whole cell (Online Figure  IA) . Importantly, coimmunostaining of sarcomeric α-actinin with JP2, which is required for anchoring and maturation of 
Novelty and Significance
What Is Known?
• Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are used for modeling heart disease and are under development for regenerating the injured myocardium.
• Inefficient excitation-contraction coupling, fetal cardiomyocyte-like Ca handling, and electrophysiological properties remain a major limitation of hiPSC-CM.
• Central to efficient excitation-contraction coupling in the human ventricle are functional T-tubules and RyR2 (ryanodine receptor 2) clustering, both of which are largely absent in hiPSC-CMs.
What New Information Does This Article Contribute?
• The addition of thyroid and glucocorticoid hormones to standard protocols promotes T-tubule development and RyR2 clustering of hiPSC-CM when cultured on extracellular matrix with physiological stiffness (Matrigel mattress).
• The new T-tubules are functional, resulting in spatially and temporally uniform Ca-induced Ca release and efficient excitation-contraction coupling that is characteristic of healthy adult ventricular myocardium.
The absence of T-tubules has remained a major concern for the use of hiPSC-CM. Although several methods have been reported that improve hiPSC-CM maturation (eg, culture on soft, patterned substrates, increased length of culture time, and hormone maturation), none of them produce functional T-tubules. We similarly observed that Matrigel mattress alone or treatment with hormone alone is not sufficient for development of T-tubules. Our work provides compelling evidence that combined activation of pathways downstream the thyroid and glucocorticoid receptors is sufficient for functional T-tubule development if hiPSC-CM are allowed to mature on a substrate of extracellular matrix with physiological stiffness. Furthermore, T3+Dex-treated cells demonstrated more widespread cellular distribution of key T-tubulerelated proteins and displayed improved RyR2 organization. As such, our discovery not only helps to overcome a major barrier in the field but also provides novel mechanistic insight into the genesis of T-tubules. In addition to promoting T-tubule development, T3+Dex also significantly increased the size of iPSC-CM, primarily cell width and cell volume (Online Figure IIIA and IIIB). Results were confirmed in a second, independently generated iPSC line (Online Figure IIIC) . However, T3+Dex treatedhiPSC-CM were still significantly smaller than adult human atrial or ventricular cardiomyocytes (Online Figure IIID) .
Are the newly formed T-tubules functional and do they contribute to EC coupling? The juxtaposition of the L-type Ca channel (LTCC) located in the T-tubule membrane with the RyR2 (ryanodine receptor) located in the junctional sarcoplasmic reticulum (SR) would be expected to synchronize SR Ca release throughout the cell. Consistent with their lack of T-tubules, 4 transverse confocal line scans of Fluo-4 loaded vehicle-treated hiPSC-CM demonstrated a U-shaped Ca release, with significantly faster Ca release at the cell periphery compared with the cell center ( Figure 1C) . In contrast, T3+Dex-treated cells exhibited a uniform Ca release across the width of the cell, with a comparable amplitude and rate of Ca rise at both center and periphery of the cell ( Figure 1C ). Together, our findings indicate functional T-tubule development in hiPSC-CM as evidenced by increased T-tubule staining, synchronization of Ca release, and improved subcellular distribution of T-tubule-related proteins.
T3+Dex-Treated hiPSC-CM Demonstrate Greater Dependence on SR Ca Release for EC Coupling
We next examined the effect of the hormone treatment on cellular Ca handling using the ratiometric Ca indicator Fura-2 AM in electrically stimulated hiPSC-CMs (Figure 2A ).
14 Although diastolic and peak Fura-2 fluorescence were not significantly different between the groups, both time to peak and Ca decay rates were significantly accelerated by hormone treatment (Figure 2B through 2D; Online Table I) . To determine what was responsible for the accelerated Ca removal, we performed a Ca flux balance analysis 18 and calculated transport rate constants for SERCA (sarco/endoplasmic reticulum Ca ATPase), NCX (Na/Ca exchanger) and non-NCX pathways (Online Table I ). T3+Dex-treated cells displayed faster Ca efflux via SERCA2 and NCX, although no differences in SR content were found (Online Table  I ). Consistent with the improved Ca handling, cell shortening and contractile kinetics measured by edge detection 14 were also significantly enhanced by T3+Dex (Online Table II) .
To examine the contribution of SR Ca release to Ca handling, we repeated whole-cell Ca fluorescence recordings after blocking SR Ca release with thapsigargin and ryanodine ( Figure 2E ). T3+Dex-treated cells displayed a greater reduction in Ca transient amplitude after SR blockade ( Figure 2F ). Both groups demonstrated a similar delay in time to peak after SR blockade (42% and 54% longer; Figure 2G ). Furthermore, Ca decay was significantly slower (ie, increased τ) in the T3+Dex-treated compared with vehicle-treated cells ( Figure 2H ). Taken together, T3+Dex produced cells with a greater contribution of SR Ca release to CICR and an overall improvement in EC coupling.
T3+Dex Increases Cell Capacitance and EC Coupling Gain
We next quantified the efficiency of coupling between LTCC current and SR-mediated Ca release by measuring the EC coupling gain in voltage-clamped hiPSC-CM. EC coupling gain was calculated as the ratio of the amplitude of the cytoplasmic Ca release to the corresponding amplitude of the LTCC current at each membrane voltage. T3+Dex-treated cells exhibited a greater rise in intracellular Ca for the respective membrane Ca current at each membrane potential ( Figure 3A ). On average, T3+Dex treatment significantly increased Ca transient amplitude, despite reduced LTCC current density ( Figure 3B) . As a result, EC coupling gain was increased at most membrane potentials ( Figure 3C ). Equivalent SR Ca content was confirmed by rapid caffeine application after each voltage protocol ( Figure 3D) . Cell capacitance-a measure of cell surface membranes that includes T-tubules 19 -was significantly increased in the T3+Dex group ( Figure 3E) . The increase in cell capacitance (93%) was greater than the increase in cell surface area measured by 3D reconstruction, which excludes any membrane invaginations (54%; Online Figure IIIB) . This result provides further evidence that the T-tubules formed after T3+Dex treatment were electrically connected to the sarcolemma.
A characteristic consequence of greater spatial proximity of LTCC, located primarily in T-tubules, and RyR2, located in the junctional SR, is faster LTCC inactivation. To assess this, a longer depolarization step was used to measure both voltage-dependent inactivation (τ1) and Cadependent inactivation (τ2; Online Figure IVA) . The significant acceleration of τ2 but not τ1 (Online Figure IVB and IVC) also supports closer spatial proximity of RyR2 and LTCC that occurs when T-tubules are present. Taken together, these results establish that T3+Dex enhances the efficiency of CICR in hiPSC-CM.
T3+Dex Enhances Elementary Ca Release (Ca Sparks) and RyR2 Organization
In adult ventricular myocardium, T-tubules form dyads where sarcolemmal LTCCs are closely juxtaposed to clusters of SR RyR2 Ca-release channels. As such, dyad formation promotes RyR2 clustering and hence RyR2-mediated Ca release. The activity of RyR2 clusters but not that of single isolated RyR2 can be assessed by measuring Ca sparks. 20 To date, only a few reports exist on the presence of Ca sparks in hiPSC-CM. [21] [22] [23] [24] Representative longitudinal line scans of Ca sparks are shown in Figure 4A . T3+Dex treatment increased spark frequency, spark amplitude, and spark mass, with no significant differences in SR Ca content (Figure 4B through 4E ; Online Table III) . Because RyR2 function was improved, we next assessed the structural organization of RyR2. Consistent with literature reports, vehicle-treated cells showed diffuse RyR2 staining with predominant perinuclear localization. 25 In contrast, T3+Dex-treated cells displayed reduced perinuclear RyR2 staining with striated organization and RyR2 clustering ( Figure 4F ). Taken together, these results provide evidence for enhanced organization and function of RyR2 in T3+Dex-treated cells.
Discussion
Here, we report that a simple culture method-addition of T3+Dex during days 16 to 30 of cardiac induction followed by a 5-day culture on a Matrigel mattress-was sufficient to generate extensive T-tubule development in hiPSC-CM. Although still less organized than in adult human myocardium, the new T-tubules were electrically coupled to the cell surface and drastically enhanced CICR and EC coupling gain. T3+Dex promoted a more ventricular-like RyR2 organization, which likely contributed to the robust appearance of Ca 2+ sparks and the greater participation of SR Ca handling to the EC coupling process. This finding is also supported by our data showing a significant reduction (Figure 3 ) in LTCC current in T3+Dex-treated cells, further evidence for increased coupling between the RyR2 and LTCC that allows for more efficient negative feedback of SR Ca release on LTCC (ie, increased Ca-dependent inactivation of LTCC; Online Figure IV) . The results reported here represent a significant advancement because previous approaches that accelerate hiPSC-CM maturation (ie, addition of growth factors, length The Matrigel mattress method (and others) has facilitated maturation of electrophysiological and Ca-handling properties of hiPSC-CM, thereby demonstrating the importance of extracellular matrix for maturation. 2, 8, 14 Thyroid and glucocorticoid hormones are essential for optimal fetal and neonatal heart development and can also enhance hiPSC-CM maturation. 13 However, our results suggest that standard differentiation medium contains suboptimal concentrations of both hormones. Our findings highlight the importance of increasing fetal maturation factors during hiPSC-CM differentiation, as well as the substrate dependence for promoting optimal cardiomyocyte development. Although mechanisms underlying this process are not yet elucidated, our data suggest that addition of T3+Dex primes the cardiomyocytes for functional and structural maturation and, when receiving proper substrate cues, is able to express these improvements.
In summary, our results suggest a permissive role of combined thyroid and glucocorticoid hormones during the cardiac differentiation process, which, when coupled with further maturation on Matrigel mattress, is sufficient for robust T-tubule development, enhanced CICR, and more ventricular-like EC coupling in single hiPSC-CM. This provides proof of principle that functional T-tubule development can be achieved in single-cell culture of hiPSC-CM. The hiPSC-CM structural and functional maturation seems to be mediated by 2 features: (1) activation of pathways downstream of thyroid and glucocorticoid receptors and (2) interaction with an extracellular matrix substrate of physiological stiffness. However because our work does not provide an exhaustive list of molecular signatures of cardiomyocyte maturation, further assessment of the effects of T3+Dex mattress method on cellular metabolism and gene expression changes specific to EC coupling are warranted. Furthermore, T-tubule development in T3+Dex-treated hiPSC-CM after 5 days is less organized than in adult human myocardium and more reminiscent to that found in day 15 to 20 postnatal rat hearts. 17 Hence, future studies are required to establish optimal culture conditions to achieve further T-tubule maturation (eg, longer culture time, tuning substrate tension, and optimizing hormone concentrations). Indeed, our discovery encourages investigation of gene expression pathways downstream of thyroid and glucocorticoid receptors, and we anticipate this will yield novel targets for further maturation of hiPSC-CM. Nevertheless, the new maturation technique reported here overcomes a major barrier in the stem cell field, which will help improve the use of hiPSC-CM for disease modeling and enable future research into the molecular pathways underlying T-tubule development. 
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